Toward development of a dynamic supramolecular peptide therapy for acute ischemic stroke.

Neurotherapeutics · 2026 · PMC12976497 · PMID 41506958

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Similarly, immunofluorescence imaging showed a trend that IKVAV-PA treatment reduced immune activation and astrogliosis in the stroke brain ( Supplement Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.